About - Scailyte

Experts in single-cell science, -omics analytics, and AI.

Our new and emerging analytical device produces rich data-sets by measuring hundreds of parameters from millions of individual cells. The resulting single-cell data holds the information needed for early disease detection, but it requires sophisticated and innovative computational approaches in order to extract the relevant information.

Scailyte is an ETH Zürich spin-off with a best-in-class artificial intelligence platform for the discovery of complex disease patterns from single-cell data. Our solution provides unprecedented insight into the disease and patients’ biology and enables the discovery of new clinically-relevant biomarker signatures by uncovering human’s hidden “single-cell” secrets. Scailyte’s proprietary best-in-class data analysis platform ScaiVision™ associates multimodal single-cell datasets (RNA-/TCR-/BCR-seq, proteomics, etc.) with clinical endpoints, such as disease diagnosis, progression, severity, treatment response, and toxicity response to identify ultra-sensitive biomarker signatures and cell functionality states. The performance and clinically-relevant applications of Scailyte’s platform ScaiVision have been demonstrated in well established CAR-T cell therapies and various clinical projects in Oncology and Immunology.

We are addressing this problem by developing artificial intelligence (AI) software for single-cell data analysis. The underlying best-in-class algorithms allow us to associate patterns in single-cell data with disease status.

We provide a powerful software solution (ScaiVision), unifying our AI technology for the global medical community and delivering it to those working in drug and diagnostic R&D.

To save lives by enabling precision medicine.

Dr. Peter Nestorov

Founder & Chief Executive Officer

Peter holds a PhD in Genetics from the University of Basel and a degree in Biochemistry from the University of Tübingen. He has been working in the emerging single-cell analysis market since 2015 and this gave him the inspiration to start Scailyte as co-founder and CEO in 2017.

Dr. Corinne Solier

Chief Operating Officer

Corinne obtained a Masters in Engineering Sciences in Biotechnology and a PhD in Immunology from Université Paul Sabatier in Toulouse, France. She pursued postdoctoral studies at the City of Hope National Medical Center in the U.S.A. in the field of nuclear receptor biochemistry before joining Roche Pharmaceuticals. There, she held various positions in early research and development, intersecting with translational biomarker science, cutting-edge “omics” technologies and innovation. She joined Scailyte in 2021 as Chief Operating Officer.

Anna Dimitrova, ACCA

Chief Financial Officer

Anna is an ACCA graduate with a Master’s degree in Finance and Banking from Sofia University. Previously, she worked as a finance manager in a fast growing company, auditor in KPMG and business consultant in PwC. Anna joined the Scailyte team in 2018.

Dr. Andrius Serva

Director Corporate Development

Andrius obtained a PhD in Systems Biology from Heidelberg University in Germany and continued as researcher in oncology at the German Cancer Research Center (DKFZ) in Heidelberg. After working for single-cell biotech Fluidigm, he joined Scailyte in 2019 and has been recently promoted to lead the Corporate Development team.

Dr. Sarah Carl

Director Data Science

Sarah holds a PhD in Genetics from the University of Cambridge. She worked as a bioinformatician at the Friedrich Miescher Institute in Basel, Switzerland, for four years before joining Scailyte. Sarah joined Scailyte as a data scientist in 2018 and now serves as Director of Data Science.

Pascal Koenig

Co-Founder Ava Women & Scailyte Chair of the Board of Directors

Pascal is a co-founder and member of the board of Ava Women, big data and artificial intelligence firm in women’s health with offices in Switzerland and the USA.

Dominique Mégret

Head of Swisscom Ventures & Scailyte Board of Directors

Dominique Mégret is head of Swisscom Ventures, which he started in 2007. He joined Swisscom in 2002 as head of the Group Strategy unit.

Michael Brenner, MD

Professor of Medicine at Harvard Medical School & Scailyte Advisor to Board of Directors

Prof. Brenner is the director of Brigham and Women’s Hospital’s Human Immunology Center, which creates and performs single-cell transcriptional analysis and functional investigations.

Jean-Pierre Rosat

Founder 4FO Venture Partners & Scailyte Board of Directors

Jean-Pierre Rosat is managing partner and founder of 4FO Venture Partners, which he started in 2015.

Anna Sumeray

Biotech startup CEO, member of the Scailyte Board of Directors

Anna is a global Biotech executive and entrepreneur with broad experience of defining and building successful businesses. Advisor and investor in biotech start-ups, pioneer and general manager of European launch projects and experienced business development leader and negotiator.

Prof. Dr. Manfred Claassen

Founder & Chief Scientific Advisor AI & Single-Cell Analysis

Manfred holds degrees in both Biochemistry and Computer Science from the University of Tübingen and a PhD in the design and validation of proteome measurements from the ETH Zurich.

Prof. Dr. Michael Mueller, MD

Clinical Advisor Endometriosis

Michael is a renowned gynecologist and gynecological oncologist, and managing director of the Women’s Health Clinic at the University Hospital of Bern (Inselspital). Prof. Mueller is supporting Scailyte as a clinical advisor and expert in endometriosis and women’s health.

Prof. Dr. Petter Brodin, MD

Petter is a pioneer in single-cell analysis and, advising Scailyte in immunology and the application of single-cell technologies for clinical research. Prof. Brodin is based at the Karolinska Institute in Sweden and heads a research group that focuses on systems-level analyses of the human immune system. Prof. Brodin is a consultant pediatrician working at the Karolinska University Hospital.

Prof. Dr. Emmanuella Guenova, MD

Clinical Advisor CTCL & Immunology

Emmanuella is a dermatologist, specialist in cutaneous lymphoma and laboratory diagnostics of skin diseases, and appointed professor at the Faculty of Biology and Medicine of the University of Lausanne.

Dr. Michael Stadler

Michael received training in immunology and bioinformatics from the Universities of Lausanne and Geneva. He is a scientific advisor supporting Scailyte’s with the development of our data analytics platform.

Prof. Dr. Tomas Kalina MD

Scientific Advisor Flow Cytometry & Immuno assays

Tomas is a physician and a cytometry expert currently leading a research group focused on disorders of adaptive immunity at the Charles University in Prague. Professor Kalina is supporting Scailyte as a clinical diagnostic advisor with his expertise in cytometry standardization.

Stefan Almestrand

Scailyte Executive Advisor

Stefan is an executive advisor for Scailyte in commercial operations, strategy and corporate development. He has 10 years of experience from working for Thermo Fisher Scientific, AstraZeneca, Fluidigm and Nanostring.

Dr. Juana L. Flores-Candia, MBA

Scailyte Business Executive Advisor

Juana is a global leader in Innovation & Strategy; co-founder of one of the first Biotech startups in South America, named as the inventor on 22 patents families. Pursued scientific discoveries and built businesses in seven countries and four continents while working for Roche, DSM, Novartis, and GSK

Vijay Tiwari

Professor in Genomics at QUB & Scailyte Executive Advisor

Vijay is a Professor in Genomics at QUB, working on achieving an integrated molecular and systems-level understanding of cancer and neurological disorders.

Join the Scailyte team
Are you ready to help us transform biomedical research and healthcare? Please send us your CV, and your letter of motivation to join Scailyte, in an email to: careers@scailyte.com

To achieve our mission, we are looking for smart, passionate and dedicated individuals who share our values by dreaming big, to join our growing, energetic and fun team. We offer flexible working schedules and location.